3 short-term Biotech plays. Scott Power attended the Bioshares Biotech summit and has identified 3 stocks that he thinks are set to rise. Power says In my opinion (and assuming the broader market holds together) the following stocks are going to move higher within the short term (one to two months): 1) Impedimed (IPD) - Investor interest is strong and growing as the importance and value of the ugraded reimbursement code approaches for its technology. 2) Innate Immunotherapuetics (IIL) expects its Phase 2b MS trial to start in August. A key milestone. 3) Rhinomed (RNO) recently received FDA approval for its nasal technology as a medical device, putting more substance behind the product. The sleep and snoring product is set for launch in Oct/Nov this year. Read more here: (VIEW LINK)